Cedars-Sinai Ranked No. 8 Nationally in U.S. News & World Report
The Medical Center Also Has 12 Specialties Ranked Nationally and Six in the Top 10
Cedars-Sinai Medical Center once again has been recognized by U.S. News & World Report as one of the best hospitals in the nation. The medical center ranked No. 8 nationally in the magazine's "Best Hospitals 2019-20" analysis, matching its rank from last year among a select group of 20 Honor Roll hospitals.
Cedars-Sinai also ranked No. 2 in Southern California and No. 3 in the state.
The U.S. News rankings are based on a variety of measures, including patient outcomes, patient experience, technology and reputation (according to surveyed physicians).
The medical center had 12 specialties ranked nationally in the hospital rankings released Monday. The specialty rankings mean that Cedars-Sinai is among the top 50 hospitals in the nation in these specific areas.
Six of the specialties ranked in the top 10 in the U.S.: cardiology and heart surgery, gastroenterology and GI surgery, gynecology, pulmonology and lung surgery, nephrology and orthopaedics. Five other specialties ranked in the top 20: cancer, diabetes and endocrinology, geriatrics, neurology and neurosurgery, and urology.
Nine of the 12 specialties saw their rankings rise from last year, and four were among the top five nationally: cardiology and heart surgery (No. 3), gastroenterology and GI surgery (No. 2), orthopaedics (No. 3) and pulmonology and lung surgery (No. 4).
The 12 Cedars-Sinai specialties ranked nationally:
- Cancer (No. 12)
- Cardiology and Heart Surgery (No. 3)
- Diabetes and Endocrinology (No. 16)
- Ear, Nose and Throat (No. 38)
- Gastroenterology and GI Surgery (No. 2)
- Geriatrics (No. 12)
- Gynecology (No. 8)
- Nephrology (No. 10)
- Neurology and Neurosurgery (No. 12)
- Orthopaedics (No. 3)
- Pulmonology and Lung Surgery (No. 4)
- Urology (No. 12)
"The U.S. News rankings are a public recognition of the dedication our staff brings to our patients every day and a reflection of our contributions to advancing the science of medicine and healthcare delivery," said Thomas M. Priselac, Cedars-Sinai president and CEO. "We are proud of these results and remain committed to expanding our research, education and support in our community."